Impact of durable response of first-line systemic treatment for patients with locally advanced or metastatic urothelial carcinoma: data update of EV-302/KEYNOTE-A39 trial.

ABSTRACT:

SUBMITTER: Miyake M 

PROVIDER: S-EPMC12779424 | biostudies-literature | 2025 Dec

REPOSITORIES: biostudies-literature